Vogozen GM2 Tablets (Metformin HCl (PR), Glimepiride & Voglibose) – Advanced Diabetes Management

Vogozen GM2 Tablets combine Metformin HCl (Prolonged Release), an insulin sensitizer, Glimepiride, a sulfonylurea that stimulates insulin secretion, and Voglibose, an alpha-glucosidase inhibitor that reduces post-meal glucose spikes. This triple-action formula effectively controls Type 2 Diabetes Mellitus and helps maintain optimal blood sugar levels.

Indications & Uses:

• Type 2 Diabetes Mellitus: Helps regulate blood glucose levels and improve insulin sensitivity.
• Postprandial Hyperglycemia: Controls sudden sugar spikes after meals by delaying carbohydrate absorption.
• Insulin Resistance: Enhances insulin utilization and reduces the risk of diabetes complications.

Dosage & Administration:

• • Take as prescribed by a physician, usually once daily with meals.
• • Swallow whole; do not crush or chew.
• • Regular monitoring of blood sugar levels is recommended.

Possible Side Effects:

• • Common: Nausea, bloating, mild hypoglycemia, dizziness.
• • Rare (Seek medical help): Severe hypoglycemia, allergic reactions, lactic acidosis (in Metformin users).

Precautions & Warnings:

• • Not recommended for patients with severe kidney or liver impairment.
• • Use with caution in pregnant and breastfeeding women.
• • Regular dietary control and exercise enhance medication efficacy.

Category:

Antidiabetic | Oral Hypoglycemic Agents | Combination Therapy